{
    "Trade/Device Name(s)": [
        "Hemoglobin Variants System on Newborn Hemoglobin System with GDM and HbReview Software",
        "Hemoglobin Variants System on Newborn Screening System with GDM and HbReview Software"
    ],
    "Submitter Information": "Bio-Rad Laboratories, Inc.",
    "510(k) Number": "K171664",
    "Predicate Device Reference 510(k) Number(s)": [
        "K080911"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GKA"
    ],
    "Summary Letter Date": "August 14, 2017",
    "Summary Letter Received Date": "August 15, 2017",
    "Submission Date": "June 2, 2017",
    "Regulation Number(s)": [
        "21 CFR 864.7415"
    ],
    "Regulation Name(s)": [
        "Abnormal hemoglobin assay"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Hemoglobin F",
        "Hemoglobin A",
        "Hemoglobin S",
        "Hemoglobin D",
        "Hemoglobin C",
        "Hemoglobin E"
    ],
    "Specimen Type(s)": [
        "Neonatal blood eluted from dried blood spots"
    ],
    "Specimen Container(s)": [
        "Filter paper collection card"
    ],
    "Instrument(s)/Platform(s)": [
        "Newborn Hemoglobin System (NHS)",
        "Newborn Chromatographic Station (NCS)",
        "Newborn Auto Sampler (NAS)",
        "Hemoglobin Variants System CE Mini-Columns",
        "Workstation with Genetic Disease Management (GDM) software",
        "HbReview Software"
    ],
    "Method(s)/Technology(ies)": [
        "Ion-exchange high-performance liquid chromatography (HPLC)",
        "Dual-wavelength photometric detection",
        "Automated sample processing"
    ],
    "Methodologies": [
        "Cation exchange HPLC",
        "Pattern assignment using GDM and HbReview software"
    ],
    "Submission Type(s)": [
        "System",
        "Reagent",
        "Control",
        "Instrument",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad Hemoglobin Variants System with Newborn Hemoglobin System, GDM, and HbReview Software for qualitative screening of hemoglobin variants in neonatal dried blood spot samples using HPLC",
    "Indications for Use Summary": "For professional laboratory use as a qualitative screen to isolate and identify inherently determined abnormal (S, D, C, E) and normal (F, A) hemoglobin types in neonatal blood samples collected on filter paper using HPLC",
    "fda_folder": "Hematology"
}